RGNX
NASDAQ · Biotechnology
Regenxbio Inc
$8.03
+0.15 (+1.90%)
Open$8.02
Previous Close$7.88
Day High$8.23
Day Low$7.90
52W High$16.19
52W Low$5.46
Volume—
Avg Volume1.18M
Market Cap542.30M
P/E Ratio—
EPS$-3.79
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+130.1% upside
Current
$8.03
$8.03
Target
$18.48
$18.48
$13.35
$18.48 avg
$24.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 218.29M | 190.18M | 81.92M |
| Net Income | -248,314,540 | -194,705,598 | 13.19M |
| Profit Margin | -113.8% | -108.1% | 16.1% |
| EBITDA | -186,462,138 | -154,329,178 | 28.49M |
| Free Cash Flow | — | — | 20.59M |
| Rev Growth | +14.8% | +14.8% | +8.8% |
| Debt/Equity | 1.82 | 1.82 | 0.43 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |